Mingqing Lu

Beijing, 100039, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A single-dose mRNA vaccine protects mice from lethal Crimean-Congo hemorrhagic fever virus infection.

A single-dose mRNA vaccine protects mice from lethal Crimean-Congo hemorrhagic fever virus infection.

Journal: NPJ vaccines

Published: June 09, 2025

The mRNA vaccine encoding Gc protein confers complete protection against severe fever with thrombocytopaenia syndrome virus.

The mRNA vaccine encoding Gc protein confers complete protection against severe fever with thrombocytopaenia syndrome virus.

Journal: Vaccine

Published: June 09, 2025

Maternal Vaccination and Protective Immunity Against SARS-CoV-2 Infection in Pups.

Maternal Vaccination and Protective Immunity Against SARS-CoV-2 Infection in Pups.

Journal: Journal of medical virology

Published: December 18, 2024

Single-dose intranasal AdC68-vectored vaccines rapidly protect Syrian hamsters against lethal Nipah virus infection.

Single-dose intranasal AdC68-vectored vaccines rapidly protect Syrian hamsters against lethal Nipah virus infection.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 13, 2024

A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection.

A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection.

Journal: iScience

Published: May 02, 2024

Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.

Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.

Journal: Emerging microbes & infections

Published: February 20, 2024

A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.

A highly effective ferritin-based divalent nanoparticle vaccine shields Syrian hamsters against lethal Nipah virus.

Journal: Frontiers in immunology

Published: February 18, 2024

Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection.

Vaccines based on the fusion protein consensus sequence protect Syrian hamsters from Nipah virus infection.

Journal: JCI insight

Published: September 05, 2023

Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection.

Both chimpanzee adenovirus-vectored and DNA vaccines induced long-term immunity against Nipah virus infection.

Journal: NPJ vaccines

Published: May 16, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026